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Available online 21 March 2016AbstractObjective: The aim of present study is to evaluate the effect of Saraca indica extract for the management of dexamethasone-induced osteoporosis
in rats.
Methods: Female Wister rats were used for the investigation of antiosteoporotic activity of S. indica extract at the dose of 200 mg/kg/day, orally
and various parameters such as alkaline phosphatase estimation, bone density, bone biomechanical strength, and ash value of bone were
determined in dexamethasone-induced osteoporosis.
Results: Alkaline phosphatase level in the blood serum and ash value of the bone was found to be significant ( p < 0.05) in the extract group as
compared to the osteoporotic group while bone density and bone biomechanical strength of the femur bone of the extract group was found to be
more than the osteoporotic group.
Conclusion: Saraca indica extract showed positive results in bone density, percentage ash value and biomechanical strength of rats.
Copyright © 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ashoka is a Sanskrit word that means “without sorrow”. It
is one of the most legendary and sacred trees of India. Ashoka
tree is universally known by its binomial Latin name Saraca
indica (Roxb.) De Wild or Saraca asoca belonging to family
Caesalpinaceae. It is found throughout India and is used in
many pharmacological activities, such as anticancer, anti-
menorrhagic, antioxytoxic, and antimicrobial activity, and has
extended use in ayurveda, unani, and homeopathy.1 In tradi-
tional literature, ashoka is reported to be used in leprosy,2
wounds, snake bites, eye diseases, neurological, uterine dis-
order, fever, cough, and fracture of bones.3 It contains, b-
sitosterol, quercetin, kaempferol, epigenin, flavonoids,* Corresponding author. Pharmacognosy and Phytochemistry Division, VNS
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).saponins, glycosides, sterols, tannins, calechor, octacosanol,
epicatechin, procyanidin, catechin, glucosides, and leucocya-
nidine. Ashoka bark is traditionally administered in the form of
a milk decoction.4
Corticosteroid-induced osteoporosis came into light when
studies on Cushing syndrom e showed tendency of bone
fracture due to excess of corticosteroid. There is a correlation
between cumulative dose of corticosteroid and decrease in
bone mineral density.5 At higher concentration, corticosteroid
reduces osteoblast activity and its differentiation. It blocks
calcium absorption and increases activity of parathyroid hor-
mone on osteoblast cells. It also affect messengers of bone and
decreases secretion of gonadal steroids.6
Osteoblast cells are bone-forming cells and osteoclast cells
are bone resorbing cells. Alkaline phosphatase (ALP) is a
measure of osteoblast cells. Thus, the present investigation
observed the change in ALP level, bone density, bone
biomechanical strength and ash value of femur bone of femaley Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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osteoporosis.
2. Materials and methods2.1. Collection, authentication and drying of plant
materialThe bark of Saraca indica (SI) tree was collected from
Kamla Garden, Bhopal district of Madhya Pradesh, India,
identified and authenticated by botanist Dr Zia-ul Hasan at
Safia College and a voucher specimen (No. 202/bot/safia/10)
was submitted. Bark was washed, dried, and powdered. The
powdered plant bark of SI was successively extracted with
various solvents: petroleum ether, chloroform, ethyl acetate,
and hydroalcoholic solution. All the above extracts were
mixed together in order to obtain the whole extract of SI.2.2. Phytochemical screeningIn preliminary phytochemical screening, various chemical
tests were performed for the identification of common phy-
toconstituents in SI extracts. The tests confirmed the presence
of common constituents such as lipids, steroids, glycosides,
flavonoids, tannins and phenolic compounds.7,82.3. Experimental animalsA total of 32 female rats weighing 100e150g were housed
in the animal house in sanitized polypropylene cages con-
taining paddy husk bedding. The animals were maintained
under controlled conditions of temperature (23 ± 2C), hu-
midity (50± 5%), and a 12-h lightedark cycle. These rats were
allowed free access to water and fed on a commercial diet. The
study conducted were approved by the Institutional animal
ethical committee (Registration No. 778/03/C/CPCSEA),
VNS Institute of Pharmacy, Bhopal.2.4. Acute toxicityVarious extracts of SI administered separately up to
2000 mg/kg body weight, none of the extracts produced any
toxic symptoms of mortality, and hence the drugs were
considered safe for further pharmacological screening.92.5. Model establishmentAntiosteoporotic activity was performed using
dexamethasone-induced osteoporosis in female rats.10 The ani-
mals were divided into four groups, eight animals in each group.
Group 1was kept as control group (positive control);Group 2was
treated with dexamethasone (negative control); Group 3 was
treated with dexamethasone and standard drug sodium alendro-
nate (0.2 mg/animal/day, orally); and Group 4 with dexametha-
sone along with mixed extracts (200 mg/kg/day, orally) of SI.
After 7 days of acclimatization, the female Wistar rats were
given (except Group 1) dexamethasone sodium phosphate at7 mg/kg (Decadron 4 mg/2 ml; Wockhardt, Mumbai, India)
i.m. once a week up to 4 weeks. Weight of rats was observed
during induction of osteoporosis and their treatment. A stan-
dard drug (sodium alendronate; 0.2 mg/animal/d orally) in
Group 3, and mixed SI extracts (200 mg/kg) in Group 4 was
administered for 15 days after 2 weeks of administration of
Decadron.3,11,122.6. Analysis of parameters
2.6.1. Measurement of ALP
Blood samples of all rats were collected by orbital puncture
of the left eye at the start and end of the protocol. Blood serum
was separated from blood by cold centrifugation (Remi
cooling centrifuge) at 1000 rpm for 20 min; 20 mL of serum
was collected in Eppendorf tubes, 1000 mL of alkaline phos-
phatase reagent (Vital Diagnostics, PVT) was added in the
same tube, and shaken; this process was carried out in dark
and samples were analyzed in an auto analyzer (Starplus).2.6.2. Measurement of bone density
Air entrapped in the pores of bone was removed using a
vacuum pump. Density of bone was calculated by calculating
mass/volume of bone. To calculate volume of bone, bone was
weighed; then it was transferred to conical flask filled with
certain amount of water, then, weight of water was calculated,
where weight of bone x, weight of water with bonew2, weight
of water¼ (w2 e x); therefore, volume of water¼ (w2 e x)/d,
(where d density of water). In another flask, the same amount
of water was weighed (w3) and volume of w3 (v3) was
calculated using mass/density; the volume of bone was
calculated using the following formula:
Volume of bone v3eðw2exÞ=d
Finally, density of bone was calculated:
Density of bone ¼ x=volumeofbone
2.6.3. Femur mechanical strength
Femur mechanical strength was measured using a three-
point bending technique. Femur was fixed at two ends and
weights were suspended at the middle of the bone. The weight
at which the bone breaks is the mechanical strength of the
bone.
2.6.4. Ash value
Ash value is the measure of inorganic contents of bone.
Femur was kept at 600C in a muffle furnace until the weight of
bone became constant. The final weight of bone was measured.2.7. Statistical analysisThe data were analyzed by using GraphPad prism software;
one way analysis of variance was employed for the compari-
son of various experimental groups. A p-value < 0.05 was
considered as statistically significant.
Table 1
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Change in alkaline phosphatase level (u/L) in female rats before (0 day) and
after (31st day) treatment.
Group Control Osteoporotic Standard Extract
3.1. Change in ALP level in female rats before and after
treatment9.833± 0.867 799.50± 5.107* 752.25± 2.658* 755.25± 0.627*
n¼ 8 albino rats per group; values are mean± standard error of the mean;
*p < 0.05 (comparison of osteoporotic and extract group with control group).
Table 2
Effect of Saraca indica extract on bone density (g/cm3) of femur.
Group Control Osteoporotic Standard ExtractALP level was found to be increased over the normal level
(16e50 u/L in 100 mg rats) in blood serum of osteoporotic rats
as compare to control rats (Figure 1). This confirmed that
osteoporosis was induced in all rats other than control rats
while treated rats showed still higher ALP level than the
osteoporotic rats which indicates prevention of bone loss by
plant extract (Table 1).1.016± 0.156 0.897± 0.111 0.989± 0.047 0.957± 0.042
n¼ 8 albino rats per group; values are mean± standard error of the mean;3.2. Measurement of bone density of femur
*p < 0.05 (comparison of osteoporotic and extract group with control group).
Table 3
Effect of Saraca indica extract on biomechanical strength of femur (kg).Increase in bone density was observed in extract group
(0.957 ± 0.042 g/cm3) in comparison to osteoporotic group
(0.897 ± 0.111 g/cm3; Table 2).Group Control Osteoporotic Standard Extract
3.733± 0.384 2.723± 0.027* 3.092± 0.102 3.117± 0.1743.3. Measurement of biomechanical strength of femurn¼ 8 albino rats per group; values are mean± standard error of the mean;
*p < 0.05 (comparison of osteoporotic and extract group with control group).
Table 4
Effect of Saraca indica extract on ash value of femur (mg).
Group Control Osteoporotic Standard Extract
0.194± 0.012* 0.058± 0.016* 0.073± 0.007* 0.077± 0.005*The mean biomechanical strength of femur in different
groups were examined where, increase in biomechanical
strength was observed in the SI extract group
(3.117 ± 0.174 kg) in comparison to osteoporotic group
(2.723 ± 0.027 kg; Table 3).n¼ 8 albino rats per group; values are mean± standard error of the mean;3.4. Measurement of ash value of femur
*p < 0.05 (Comparison of osteoporotic and extract group with control group).Increase in mean ash value of femur was observed in the SI
extract group (0.077 ± 0.005 mg) as compared to the osteo-
porotic group (0.058 ± 0.016 mg; Table 4).
Our results showed significant increase in ALP level and
ash value of femur bone of female rats (Figure 2).Figure 1. Change in alkali4. Discussion
The aim of the present study is to evaluate the effect of SI
extract on the management of glucocorticoid-induced osteo-
porosis. Previous studies have suggested that glucocorticoidne phosphatase level.
Figure 2. Changes in bone density, Biomechanical strength and ash value.
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number of osteoblast cells by apoptosis13; presently, the best
osteoporosis treatments are biphosphonates, compounds that
decrease the osteoclast resorptive activity.
Remodeling is an important phenomenon that takes place in
bone. During osteoporosis, resorption activity of osteoclast
cells is increased; in order to balance this change, formation of
bone takes place by increasing the number of osteoblast cells.
Consequently, secretion of ALP by osteoblast cells also in-
creases; thus ALP is a biomarker of osteoblast cells. During
the treatment of osteoporosis, number of osteoblast cells were
increased, which again results in increase in ALP level.
Therefore, in order to observe the change in osteoblast, change
in ALP level was observed in present study. SI bark is
administered traditionally in milk decoction; therefore, to
simulate the formulation as used in traditional way, whole
extract (mixture of petroleum ether, chloroform, ethylacetete
and hydroalcoholic 1:1 extract) of SI was mixed in milk and
administered to the female rats. A separate group of vehicle
control (milk) was studied to nullify the effect of milk, whose
readings are not included in the paper. In present protocol, 1/
10 of the LD50 dose was selected for treatment, while duration
of the protocol was selected on the basis of duration of
treatment of standard drug.
5. Conclusion
The results obtained in the present study provide evidence
that SI contributes to the healing of osteoporosis. It showed
positive results in bone density, percentage ash value and
biomechanical strength of rats.
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